nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0466	0.108	CbGpPWpGaD
Glucosamine—NFKB2—heart—hypothyroidism	0.0421	0.0739	CbGeAlD
Glucosamine—NFKB2—pituitary gland—hypothyroidism	0.0351	0.0618	CbGeAlD
Glucosamine—CYP2C19—urine—hypothyroidism	0.032	0.0563	CbGeAlD
Glucosamine—TNF—blood—hypothyroidism	0.0318	0.056	CbGeAlD
Glucosamine—NFKB2—adrenal gland—hypothyroidism	0.0314	0.0552	CbGeAlD
Glucosamine—NFKB2—blood—hypothyroidism	0.0314	0.0552	CbGeAlD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0303	0.0703	CbGpPWpGaD
Glucosamine—NFKB2—thyroid gland—hypothyroidism	0.0303	0.0532	CbGeAlD
Glucosamine—NFKB2—female gonad—hypothyroidism	0.0293	0.0514	CbGeAlD
Glucosamine—IFNG—heart—hypothyroidism	0.0285	0.0501	CbGeAlD
Glucosamine—IFNG—cardiovascular system—hypothyroidism	0.0269	0.0473	CbGeAlD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0265	0.0614	CbGpPWpGaD
Glucosamine—NFKB2—testis—hypothyroidism	0.026	0.0456	CbGeAlD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.0258	0.0598	CbGpPWpGaD
Glucosamine—NFKB2—liver—hypothyroidism	0.0245	0.0431	CbGeAlD
Glucosamine—CYP2E1—urine—hypothyroidism	0.0235	0.0414	CbGeAlD
Glucosamine—TNF—EV release from cardiac cells and their functional effects—PRL—hypothyroidism	0.0218	0.0505	CbGpPWpGaD
Glucosamine—IFNG—blood—hypothyroidism	0.0213	0.0374	CbGeAlD
Glucosamine—MMP9—Endochondral Ossification—THRA—hypothyroidism	0.021	0.0488	CbGpPWpGaD
Glucosamine—MMP9—heart—hypothyroidism	0.0183	0.0322	CbGeAlD
Glucosamine—TNF—Monoamine Transport—SLC5A7—hypothyroidism	0.0183	0.0424	CbGpPWpGaD
Glucosamine—MMP9—cardiovascular system—hypothyroidism	0.0173	0.0304	CbGeAlD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.017	0.0396	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0168	0.0389	CbGpPWpGaD
Glucosamine—IFNG—liver—hypothyroidism	0.0166	0.0292	CbGeAlD
Glucosamine—MMP9—EPH-ephrin mediated repulsion of cells—CLTC—hypothyroidism	0.015	0.0347	CbGpPWpGaD
Glucosamine—MMP9—adrenal gland—hypothyroidism	0.0137	0.024	CbGeAlD
Glucosamine—MMP9—blood—hypothyroidism	0.0137	0.024	CbGeAlD
Glucosamine—MMP9—female gonad—hypothyroidism	0.0127	0.0224	CbGeAlD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—hypothyroidism	0.0127	0.0295	CbGpPWpGaD
Glucosamine—MMP9—testis—hypothyroidism	0.0113	0.0199	CbGeAlD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0108	0.0251	CbGpPWpGaD
Glucosamine—MMP9—liver—hypothyroidism	0.0107	0.0188	CbGeAlD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.0103	0.0238	CbGpPWpGaD
Glucosamine—MMP9—Osteopontin-mediated events—VAV3—hypothyroidism	0.01	0.0232	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—BGLAP—hypothyroidism	0.0094	0.0218	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00888	0.0206	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00873	0.0203	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00867	0.0201	CbGpPWpGaD
Glucosamine—MMP9—EPH-ephrin mediated repulsion of cells—VAV3—hypothyroidism	0.00705	0.0163	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00655	0.0152	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00631	0.0146	CbGpPWpGaD
Glucosamine—CYP2C19—blood—hypothyroidism	0.00613	0.0108	CbGeAlD
Glucosamine—CYP2E1—cardiovascular system—hypothyroidism	0.00569	0.01	CbGeAlD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00492	0.0114	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IGF1—hypothyroidism	0.00492	0.0114	CbGpPWpGaD
Glucosamine—CYP2C19—liver—hypothyroidism	0.00479	0.00842	CbGeAlD
Glucosamine—CYP2E1—adrenal gland—hypothyroidism	0.0045	0.00791	CbGeAlD
Glucosamine—CYP2E1—blood—hypothyroidism	0.0045	0.00791	CbGeAlD
Glucosamine—CYP2E1—thyroid gland—hypothyroidism	0.00434	0.00763	CbGeAlD
Glucosamine—MMP9—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00434	0.0101	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00431	0.00999	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00412	0.00955	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00407	0.00944	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—VAV3—hypothyroidism	0.00399	0.00925	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00388	0.009	CbGpPWpGaD
Glucosamine—CYP2E1—testis—hypothyroidism	0.00372	0.00654	CbGeAlD
Glucosamine—CYP2E1—liver—hypothyroidism	0.00352	0.00618	CbGeAlD
Glucosamine—MMP9—Endochondral Ossification—IGF1—hypothyroidism	0.00345	0.008	CbGpPWpGaD
Glucosamine—CYP2E1—cerebellum—hypothyroidism	0.00344	0.00604	CbGeAlD
Glucosamine—MMP9—Axon guidance—CLTC—hypothyroidism	0.00325	0.00753	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.00306	0.0071	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.00303	0.00702	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—IGF1—hypothyroidism	0.00266	0.00616	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.00245	0.00569	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00238	0.00553	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CLTC—hypothyroidism	0.00232	0.00537	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CLTC—hypothyroidism	0.00194	0.0045	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.0017	0.00394	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—IGF1—hypothyroidism	0.0017	0.00394	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00162	0.00376	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CLTC—hypothyroidism	0.00157	0.00365	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—VAV3—hypothyroidism	0.00157	0.00364	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VAV3—hypothyroidism	0.00153	0.00355	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CLTC—hypothyroidism	0.00142	0.00329	CbGpPWpGaD
Glucosamine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00135	0.00312	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IGF1—hypothyroidism	0.0012	0.00278	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VAV3—hypothyroidism	0.00109	0.00253	CbGpPWpGaD
Glucosamine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00109	0.00253	CbGpPWpGaD
Glucosamine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00104	0.00241	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PRL—hypothyroidism	0.000988	0.00229	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—VAV3—hypothyroidism	0.000914	0.00212	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00088	0.00204	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000841	0.00195	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PRL—hypothyroidism	0.000801	0.00186	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CLTC—hypothyroidism	0.00077	0.00179	CbGpPWpGaD
Glucosamine—IFNG—Immune System—VAV3—hypothyroidism	0.000741	0.00172	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—IYD—hypothyroidism	0.000683	0.00159	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VAV3—hypothyroidism	0.000668	0.00155	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TRH—hypothyroidism	0.000666	0.00154	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TSHB—hypothyroidism	0.000593	0.00138	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TSHR—hypothyroidism	0.000593	0.00138	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000581	0.00135	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.000579	0.00134	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TPO—hypothyroidism	0.000546	0.00127	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SH2B3—hypothyroidism	0.000529	0.00123	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—IYD—hypothyroidism	0.000527	0.00122	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000448	0.00104	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000447	0.00104	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TPO—hypothyroidism	0.000421	0.000978	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PRL—hypothyroidism	0.000392	0.00091	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000391	0.000906	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VAV3—hypothyroidism	0.000363	0.000842	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AVP—hypothyroidism	0.00035	0.000811	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TSHB—hypothyroidism	0.000253	0.000587	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—POMC—hypothyroidism	0.000232	0.000539	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	0.000225	0.000523	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1—hypothyroidism	0.000224	0.000519	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TSHB—hypothyroidism	0.000195	0.000453	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC5A5—hypothyroidism	0.000189	0.000439	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	0.000174	0.000404	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000172	0.000398	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	0.000146	0.000339	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—POMC—hypothyroidism	9.91e-05	0.00023	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—POMC—hypothyroidism	7.64e-05	0.000177	CbGpPWpGaD
